Sfoglia per Autore
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
2011 L. Malcovati, E. Papaemmanuil, D.T. Bowen, J. Boultwood, M.G. Della Porta, C. Pascutto, E. Travaglino, M.J. Groves, A.L. Godfrey, I. Ambaglio, A. Galli, M.C. Da Via', S. Conte, S. Tauro, N. Keenan, A. Hyslop, J. Hinton, L.J. Mudie, J.S. Wainscoat, P.A. Futreal, M.R. Stratton, P.J. Campbell, E. Hellstrom-Lindberg, M. Cazzola
JAK2 GGCC haplotype in MPL mutated myeloproliferative neoplasms
2012 D. Pietra, I. Casetti, M.C. Da Vià, C. Elena, C. Milanesi, E. Rumi
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms
2012 L. Arcaini, S. Zibellini, E. Boveri, R. Riboni, S. Rattotti, M. Varettoni, M.L. Guerrera, M. Lucioni, A. Tenore, M. Merli, S. Rizzi, L. Morello, C. Cavalloni, M.C. Da Via, M. Paulli, M. Cazzola
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1
2013 I. Ambaglio, L. Malcovati, E. Papaemmanuil, C.M. Laarakkers, M.G. Della Porta, A. Galli, M.C. Da Vià, E. Bono, M. Ubezio, E. Travaglino, R. Albertini, P.J. Campbell, D.W. Swinkels, M. Cazzola
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia
2014 L. Malcovati, E. Papaemmanuil, I. Ambaglio, C. Elena, A. Galli, M.G. Della Porta, E. Travaglino, D. Pietra, C. Pascutto, M. Ubezio, E. Bono, M.C. Da Via, A. Brisci, F. Bruno, L. Cremonesi, M. Ferrari, E. Boveri, R. Invernizzi, P.J. Campbell, M. Cazzola
Pre-Chemotherapy risk factors for invasive fungal diseases : Prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (seifem 2010-a multicenter study)
2015 M. Caira, A. Candoni, L. Verga, A. Busca, M. Delia, A. Nosari, C. Caramatti, C. Castagnola, C. Cattaneo, R. Fanci, A. Chierichini, L. Melillo, M.E. Mitra, M. Picardi, L. Potenza, P. Salutari, N. Vianelli, L. Facchini, M. Cesarini, M.R. De Paolis, R. Di Blasi, F. Farina, A. Venditti, A. Ferrari, M. Garzia, C. Gasbarrino, R. Invernizzi, F. Lessi, A. Manna, B. Martino, G. Nadali, M. Offidani, L. Paris, V. Pavone, G. Rossi, A. Spadea, G. Specchia, E.M. Trecarichi, A. Vacca, S. Cesaro, V. Perriello, F. Aversa, M. Tumbarello, L. Pagano, R. Ragionieri, O.S. Orsola-Malpighi, F. Antoniazzi, S. Storti, M. Luppi, S. Pagliuca, E. Rossetti, M.C. Dà Via, L. Di Caprio, I. Majolino, N. Cascavilla, G. Turri, R. Fanin
Minimal morphological criteria for defining bone marrow dysplasia : a basis for clinical implementation of WHO classification of myelodysplastic syndromes
2015 M. Della Porta, E. Travaglino, E. Boveri, M. Ponzoni, L. Malcovati, E. Papaemmanuil, G. Rigolin, C. Pascutto, G. Croci, U. Gianelli, R. Milani, I. Ambaglio, C. Elena, M. Ubezio, M. Da Via', E. Bono, D. Pietra, F. Quaglia, R. Bastia, V. Ferretti, A. Cuneo, E. Morra, P. Campbell, A. Orazi, R. Invernizzi, M. Cazzola, G.A. Croci
Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndrome
2015 M. Varettoni, E. Marchioni, M. Bonfichi, A. Picchiecchio, L. Arcaini, C. Arbasino, M. Gotti, M. Da Via, M. Delmonte, R. Sciarra, M. Cazzola
Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients : results of a prospective study by the Rete Ematologica Lombarda (Rel)
2016 C. Cattaneo, P. Zappasodi, V. Mancini, C. Annaloro, F. Pavesi, C. Skert, A. Ferrario, E. Todisco, V. Sacca, L. Verga, A. Passi, M.C. Da Vià, S. Ferrari, G. Mometto, M. Petulla, A. Nosari, G. Rossi
Hexokinase-2 Expression in MET-positive FDG-negative Multiple Myeloma
2018 S. Kircher, A. Stolzenburg, K. Kortüm, M. Kircher, M.C. DA VIA', S. Samnick, A. Buck, H. Einsele, A. Rosenwald, C. Lapa
Protocol for M3P: A comprehensive and clinical oriented targeted sequencing panel for routine molecular analysis in multiple myeloma
2018 S. Barrio, M.C. DA VIA', L. Bruins, T. Stuhmer, T. Steinbrunn, M. Bittrich, H. Einsele, A.K. Stewart, E. Braggio, K.M. Kortum
Secondary acute myeloid leukaemia in elderly patients : Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions : an analysis of 280 patients by the network rete ematologica lombarda (REL)
2018 E. Borlenghi, C. Pagani, P. Zappasodi, M. Bernardi, C. Basilico, E. Todisco, N. Fracchiolla, V. Mancini, M. Turrini, M. Da Vià, E. Sala, C. Cattaneo, M. Petullà, F. Serana, A. Ferrario, R. Cairoli, A. Cortelezzi, A. Santoro, C. Castagnola, G. Rossi
Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network
2018 P. Zappasodi, L. Marbello, E. Borlenghi, M. Fumagalli, M. Bernardi, N. Fracchiolla, V. Mancini, M. Da Via, E. Ravano, E. Cerqui, V.V. Ferretti, B. Rocca, C. Calvello, M. Cazzola, C. Castagnola, G. Rossi
Gene expression comparison between the lymph node-positive and -negative reveals a peculiar immune microenvironment signature and a theranostic role for WNT targeting in pancreatic ductal adenocarcinoma: A pilot study
2019 A. Argentiero, S. De Summa, R. Di Fonte, R.M. Iacobazzi, L. Porcelli, M. Da Via, O. Brunetti, A. Azzariti, N. Silvestris, A.G. Solimando
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment
2019 A.G. Solimando, M.C. Da Vià, S. Cicco, P. Leone, G. Di Lernia, D. Giannico, V. Desantis, M.A. Frassanito, A. Morizio, J. Delgado Tascon, A. Melaccio, I. Saltarella, G. Ranieri, R. Ria, L. Rasche, K.M. Kortüm, A. Beilhack, V. Racanelli, A. Vacca, H. Einsele
Spectrum and functional validation of PSMB5 mutations in multiple myeloma
2019 S. Barrio, T. Stuhmer, M.C. Da Vià, C. Barrio-Garcia, N. Lehners, A. Besse, I. Cuenca, A. Garitano-Trojaola, S. Fink, E. Leich, M. Chatterjee, C. Driessen, J. Martinez-Lopez, A. Rosenwald, R. Beckmann, R.C. Bargou, E. Braggio, A.K. Stewart, M.S. Raab, H. Einsele, K.M. Kortum
Hierarchy of mono- And biallelic TP53 alterations in multiple myeloma cell fitness
2019 U. Munawar, L. Rasche, N. Muller, C. Vogt, M.C. Da Vià, L. Haertle, P. Arampatzi, S. Dietrich, M. Roth, A. Garitano-Trojaola, M.J. Steinhardt, S. Strifler, M. Gallardo, J. Martinez-Lopez, R.C. Bargou, T. Heckel, H. Einsele, T. Stuhmer, K.M. Kortum, S. Barrio
Comparison of 11C-Choline and 11C-Methionine PET/CT in Multiple Myeloma
2019 C. Lapa, M. Kircher, M.C. Da Via, M. Schreder, L. Rasche, K.M. Kortum, H. Einsele, A.K. Buck, H. Hanscheid, S. Samnick
CIC mutation as a molecular mechanism of acquired resistance to combined braf-mek inhibition in extramedullary multiple myeloma with central nervous system involvement
2020 M.C. Da Via, A.G. Solimando, A. Garitano-Trojaola, S. Barrio, U. Munawar, S. Strifler, L. Haertle, N. Rhodes, E. Teufel, C. Vogt, C. Lapa, A. Beilhack, L. Rasche, H. Einsele, K.M. Kortum
Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes
2020 M.J. Steinhardt, E. Wiercinska, M. Pham, G.U. Grigoleit, A. Mazzoni, M.C. DA VIA', X. Zhou, K. Meckel, K. Nickel, J. Duell, F.C. Krummenast, S. Kraus, C. Hopkinson, B. Weissbrich, W. Mullges, G. Stoll, K.M. Kortum, H. Einsele, H. Bonig, L. Rasche
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile